SYSTEMS AND METHODS FOR PATTERNING AND SPATIAL ELECTROCHEMICAL MAPPING OF CELLS
20230014082 · 2023-01-19
Assignee
Inventors
- Hongkun Park (Cambridge, MA, US)
- Jeffrey T. Abbott (Cambridge, MA, US)
- Wenxuan Wu (Cambridge, MA, US)
- Tianyang Ye (Cambridge, MA, US)
- Han Sae Jung (Cambridge, MA, US)
- Donhee Ham (Cambridge, MA, US)
Cpc classification
B01J19/087
PERFORMING OPERATIONS; TRANSPORTING
G01N33/48728
PHYSICS
G01N27/3277
PHYSICS
G01N27/49
PHYSICS
International classification
Abstract
Disclosed herein are an apparatus for electrically assessing and/or manipulating cells. One aspect is directed to electrically mapping cells on the surface of the semiconductor substrate via cross-electrode impedance measurements. Further according to some aspects, the electrode array allows for spatially addressable electrical stimulation and/or recording of electrical signals in real-time using the CMOS circuitry. Some of these aspects are directed to using an electrode array to perform cell patterning through electrochemical gas generation, and extracellular electrochemical mapping.
Claims
1-22. (canceled)
23. A method for providing spatially positioned electrochemical reactions with an electrode array exposed on a surface of a semiconductor substrate, the electrode array exposed to a solution including one or more chemical or biological reagents and a plurality of cells attached to the semiconductor substrate, the method comprising: selecting one or more electrodes in the electrode array; controlling circuitry in the semiconductor substrate to apply, at the one or more electrodes, one or more stimulus signals including at least one of a patterning voltage or a patterning current for generation of gas in the solution to initiate an electrochemical reaction at the selected one or more electrodes; and generating the gas at the selected one or more electrodes to cause at least one of permeabilization or detachment from the surface of the semiconductor substrate of at least one cell of the plurality of cells disposed on the selected one or more electrodes.
24. The method of claim 23, wherein the patterning voltage exceeds a redox potential for generation of gas in the solution.
25. The method of claim 23, wherein the permeabilization of at least one cell of the plurality of cells comprises forming in the at least one cell holes that are smaller than those formed when the at least one cell is detached from the surface of the semiconductor substrate.
26. The method of claim 23, wherein the gas comprises H.sub.2, Cl.sub.2, or O.sub.2.
27. The method of claim 23, wherein the plurality of cells are a plurality of cells of a type, and the method further comprises: plating one or more cells of a second type on the surface of the semiconductor substrate at locations where the at least one cell of the first type has detached from.
28. The method of claim 23, further comprising: mapping a time sequence of regrowth of the plurality of cells on the surface at positions where the at least one cell has detached from; and based on the mapping, determining a growth rate of the plurality of cells.
29. The method of claim 28, further comprising: measuring with the controlling circuitry an open-circuit potential at each of some or all electrodes in the electrode array to measure an extracellular redox potential; and based on the mapping, determine a cellular metabolic state and respiration of the plurality of cells during growth.
30. The method of claim 28, further comprising: measuring with the control circuitry a current at each of some or all remaining electrodes in the electrode array.
31. The method of claim 23, wherein the one or more stimulus signals are relative to a current or a potential of a reference electrode.
32. The method of claim 23, wherein the semiconductor substrate includes a plurality of voltage buffer circuits coupled with the electrode array, the method further comprising: selecting a set of electrodes in the electrode array; and controlling the voltage buffer circuits to measure an extracellular redox potential at each electrode of the set of electrodes.
33. A system comprising: a semiconductor substrate comprising: an electrode array including a plurality of individually addressable electrodes disposed on a surface of the semiconductor substrate; a solution including one or more chemical or biological reagents and a plurality of cells attached to the semiconductor substrate; and circuitry that is controllable by one or more processors to apply, at a group of electrodes in the electrode array, one or more stimulus signals including at least one of a patterning voltage or a patterning current, relative to a potential of or current at an electrode in the electrode array or a potential of or current at a reference electrode, for generation of gas in the solution to initiate an electrochemical reaction at the group of electrodes and generate gas at the group of electrodes to cause at least one of permeabilization or detachment from the surface of the semiconductor substrate of at least one cell of the plurality of cells disposed on the group of electrodes.
34. The system of claim 33, wherein the electrode array comprises a plurality of pads disposed on an insulative surface of the semiconductor substrate.
35. The system of claim 34, wherein the plurality of pads comprises Au or Pt.
36. The system of claim 33, wherein the reference electrode is a Ag/AgCl reference electrode.
37. The system of claim 33, wherein the electrode array comprises at least 1000, at least 4000, or at least 1,000,000 electrodes, and the circuitry comprises a plurality of recording circuits, each recording circuit configured to measure a current at an electrode of the electrode array.
38. The system of claim 37, wherein the plurality of recording circuits comprises at least 10 recording circuits, or at least 4000 recording circuits.
39. The system of claim 37, wherein each recording circuit comprises a transimpedance amplifier (TIA).
40. The system of claim 39, wherein the TIA comprises an impedance component having a resistance of at least 10 MOhm, wherein an output voltage of the TIA is proportional to a voltage across the impedance component.
41. The system of claim 40, wherein the impedance component comprises a switching capacitor.
42. The system of claim 33, wherein the circuitry further includes a plurality of buffer circuits coupled with the electrode array, wherein the circuitry is controllable by one or more processors to measure, via the plurality of buffer circuits, an extracellular redox potential at each cell of a set of electrodes of the electrode array.
43. A system for providing spatially positioned electrochemical reactions, the system comprising: an electrode array exposed at a surface area of a semiconductor substrate; a solution including one or more chemical or biological reagents and a plurality of cells attached to the surface area of the semiconductor substrate; circuitry disposed in the semiconductor substrate and coupled to the electrode array; at least one non-transitory computer-readable medium having stored thereon executable instructions; and at least one processor programmed by the executable instructions to perform a method comprising acts of: selecting a pattern of electrodes in the electrode array; and controlling circuitry to apply, at the pattern of electrodes, one or more pre-determined stimulus signals including at least one of a patterning voltage or a patterning current, relative to a potential of or current at an electrode in the electrode array or a potential of or current at a reference electrode, for generation of gas in the solution such that gas is generated at the pattern of electrodes to cause at least one of permeabilization or detachment from the surface of the semiconductor substrate of at least one cell of the plurality of cells that is disposed on the pattern of electrodes.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0017] Various aspects and embodiments will be described with reference to the following figures. It should be appreciated that the figures are not necessarily drawn to scale. Items appearing in multiple figures are indicated by the same reference number in all the figures in which they appear. In the drawings:
[0018]
[0019]
[0020]
[0021]
[0022]
[0023]
[0024]
[0025]
[0026]
[0027]
[0028]
[0029]
[0030]
[0031]
[0032]
[0033]
[0034]
[0035]
[0036]
[0037]
[0038]
[0039]
[0040]
[0041]
[0042]
[0043]
[0044]
[0045]
[0046]
[0047]
[0048]
[0049]
[0050]
[0051]
[0052]
[0053]
[0054]
[0055]
[0056]
[0057]
[0058]
[0059]
[0060]
[0061]
[0062]
DETAILED DESCRIPTION
[0063] The present disclosure is directed to various apparatuses for electrically assessing and/or manipulating cells. In one embodiment, the apparatus includes a semiconductor substrate having complimentary metal-oxide semiconductor (CMOS) circuitry electrically interfaced with an electrode array that can also be fabricated using CMOS-compatible fabrication techniques on a surface of the semiconductor substrate and exposed to the cells. The inventors have recognized and appreciated that by using semiconductor processing techniques, an electrode array may be fabricated and integrated with active circuitry in an economical fashion. Furthermore, electrodes in an electrode array having a small electrode size and electrode-to-electrode pitch may allow for higher spatial-resolution assessment of multiple cells compared to using an electrode that is larger than a size of a cell. For example, individual cells may be distinguishable when mapped using a high density electrode array, compared to a large electrode covered by an ensemble of cells. Further according to some aspects, the electrode array allows for spatially addressable electrical stimulation and/or recording of electrical signals in real-time using the CMOS circuitry. Some of these aspects are directed to using an electrode array to perform cell patterning through electrochemical gas generation, and extracellular electrochemical mapping.
[0064] One aspect is directed to electrically mapping cells on the surface of the semiconductor substrate via cross-electrode impedance measurements. The inventors have recognized and appreciated that electrical impedance measured between two electrodes, or cross-electrode impedance, may be affected by impedance along a current path between the electrodes. As a result presence of one or more cells along the current path may affect the cross-electrode impedance, such that cells can be mapped using cross-electrode impedance measurements.
[0065]
[0066] Cross-electrode impedance between electrodes 106_1 and 106_2 may be obtained from the values of cross-electrode current and stimulus voltage between the pair of electrodes using any suitable method known in the art, for example by dividing the stimulus voltage amplitude with the cross-electrode current amplitude. A processing unit 120 may be provided that receives signals from active circuitry within the semiconductor substrate 102 and performs the determination of the cross-electrode impedance. It should be appreciated that there is no requirement to calculate the actual impedance values, and that any representative measurement that is indicative of impedance between two electrodes may be used. Alternatively or in addition to calculating the impedance value, the cross-electrode current may be used as an indicator for the cross-electrode impedance when measurements at different electrodes are compared, if the stimulus voltage amplitude is programmed to be a known constant.
[0067]
[0068] The presence of cells may alter the shape and distribution of electric field lines 114 between electrodes and in turn lead to a change in cross-electrode impedance, as discussed in detail below in relation to
[0069] The inventors have recognized and appreciated that biological cells have a lipid bilayer that forms a continuous membrane barrier around the cell. Electrically, the membrane can behave as a capacitor in parallel with a high resistance, and can have a different electrical impedance compared to the surrounding medium such as a solution containing the cells. A cell with its high-impedance membrane on top of the electrode array will then affect the current distribution in the solution such as solution 208 in
[0070] As an example for the effect of cells on cross-electrode impedance, and without wishing to be bound by a particular theory, the inventors recognized that if a cell such as cell 220 as shown in
[0071] On the other hand, if a cell is not adhered to the surface 204, or if a cell such as cell 230 as shown in
[0072] Therefore, the presence of a cell above the electrode array and whether it is adhered to the surface may be detected using cross-electrode impedance measurements. It should be appreciated that a cell that is adhered with a surface may have various degrees of non-zero separation between the outer extent of the cell membrane and the surface. An apparatus according to some aspects of the present application may provide detection for the degree in which the cell is adhered. For example, stronger adhesion will more strongly increase the cross-electrode coupling due to the smaller gap distance along the vertical direction between the cell and the surface of the semiconductor substrate.
[0073] The cross-electrode measurements may provide several advantages. For example, such measurements are non-invasive and can be made repeatedly without affecting the cell viability or the electrodes.
[0074] In some embodiments and as described above in relation with
[0075] In contrast to the cross-electrode impedance technique, the inventors have recognized that simple impedance measured at individual electrodes would fail to detect the presence of cells. In such a measurement on one electrode, the sum of all the return current is measured as the signal for the impedance on the electrode. Namely, such a measurement is an impedance measurement of an electrode only, and are not measuring the change of the electric field in the solution on the electrodes. As a result, the inventors have observed that the impedance of the electrode itself is not sensitive to the presence of a cell even if the cell is culture directly on its surface.
[0076] Referring back to
[0077] Still referring to
[0078] In some embodiments, each recording circuit comprises a transimpedance amplifier (TIA) having a switching capacitor as impedance component. The resistance of the impedance component is at least 10 MΩ (megohms), at least 100 MΩ (megohms), or between 10 MΩ and 1 GΩ (gigohm) to provide amplification of a recorded current signal at an input of the TIA, whereas an output of the TIA provides an output voltage that is proportional to the recorded current signal and to a voltage across the impedance component.
[0079] Electrodes in the electrode array 106 may be reconfigured using the active circuitry 116 as a stimulation electrode or as a recording electrode. In some embodiments, active circuitry 116 comprises routing and switching components that are programmable to connect a selected electrode of the electrode array 106 to stimulus source circuit 110, to current measuring circuit 112, or to other circuit components to enable different functionalities. Depending on the application, more than one electrode may be configured as a stimulus electrode, and more than one electrode may be recording at the same time. For example, when mapping local cell properties using cross-electrode impedance measurements, typically only one electrode acts as stimulus electrode at a time. In some other embodiments, a subset of one or more electrodes may be selected to act as a stimulus or to apply one or more potentials or currents to initiate an electrochemical reaction at the locations of the selected one or more electrodes. The latter embodiments will be discussed in more detail in the sections below regarding cell-to-cell attachment measurement, patterning, and spatial electrochemical mapping of cells.
[0080] In some embodiments, the electrodes may be biased using low impedance sources/returns in the active circuitry. For example, a low output-impedance voltage source may be used to provide a stimulus signal at a stimulus electrode, while a low input-impedance transimpedance amplifier may be provided for current measurement at a recording electrode. In such embodiments, each electrode may be selectively connected to a voltage source for stimulation, to a transimpedance amplifier for current measurement, to a voltage source for a return, or to a transimpedance amplifier for simultaneous stimulation and current measurement. The inventors have appreciated and recognized that the low impedance source/return may facilitate formation of fringing electric field lines in the solution as illustrated in the example in
[0081] Semiconductor substrate 102 may comprise silicon, and in such embodiments, active circuitry 116 may be an integrated circuit that comprises CMOS components fabricated using standard CMOS processing techniques. The electrode array 106 may be disposed within semiconductor substrate 102, for example as conductors exposed from a surface 104 of the semiconductor substrate 102 that faces the medium 108. In some embodiments, the surface 104 is an insulative surface that provides mechanical support and electrical isolation to the electrode array 106 while also providing a suitable surface for cells to grow. While
[0082] It should be appreciated that semiconductor substrate 102 may be any substrate fabricated using semiconductor processing techniques, and not limited to a silicon wafer. For example, semiconductor substrate 102 may comprise group IV semiconductor, III-V semiconductor, II-V semiconductor, sp.sup.2 hybridized carbon material, chalcogenide, metal, metallic compound, oxide, nitride, silicide, polymer material, or combinations thereof. Semiconductor substrate 102 may be a unitary component, or a composite of multiple components. Components in the semiconductor substrate 102 may comprise an active circuit layer, a wiring layer, a redistribution layer, a circuit board, or combinations thereof. Component layers in the semiconductor substrate may be formed in the addition process during CMOS processing, or be formed separately and bonded to each other using packaging techniques known in the field. Conductors are provided in the semiconductor substrate 102 that interconnects active circuitry 116 with the electrode array 106. In some embodiments, connection points are provided at a bottom surface of the semiconductor substrate for electrically interfacing components within the semiconductor substrate with processing unit 120. Electrical connection between processing unit 120 and the semiconductor substrate 102 may be provided via any suitable way, such as but not limited to controlled collapse chip connection or flip chip bonding, wire bonding, flexible cables, or wireless communication.
[0083] Referring back to
[0084] Processor 25 may be any suitable processing device, such as, for example and not limited to, one or more processors, a central processing unit (CPU), digital signal processor (DSP), controller, addressable controller, general or special purpose microprocessor, microcontroller, addressable microprocessor, programmable processor, programmable controller, dedicated processor, dedicated controller, or any other suitable processing device. Some or all components within processing unit 120 may be packaged as a system-on-a-chip (SOC). Moreover, it should be appreciated that
[0085] Turning now to the electrode array 106. In some embodiments, electrode array 106 may be patterned on the surface 104 as part of the semiconductor fabrication process to form the active circuitry 116 within semiconductor substrate 102, and may be conductive pads that comprise metal such as Au or Pt, or alloys thereof. For example, the pads may be formed of Al with plated Au as a top layer. In such embodiments, substrate 110 may additionally comprise conductors that interconnect vertically the exposed electrode array 14 to circuitry within substrate 110.
[0086] Electrodes in the electrode array 106 may be arranged on the surface 104 in any suitable arrangement, such as a two-dimensional array with regular pitches along the row and column directions. In some embodiments of the cross-electrode impedance-based mapping, a pitch of the electrode array may be selected to be on the order of or smaller than a size of typical cells such that a cell can cover at least two electrodes to increase coupling between the cell and the at least two electrodes. For example, when the size of cells is about 30 μm, the pitch of the electrode array may be set as less than 30 μm, less than 20 μm, less than 5 μm, or between 1 and 20 μm. Providing a small pitch between electrodes allows a cell to cover two or more electrodes, which permits measuring the cell-to-substrate gap distance via an increase in cross-electrode coupling at the electrodes under the cell.
[0087] In some embodiments where the electrode array is fabricated during a CMOS-compatible fabrication process on top of the semiconductor substrate containing CMOS active circuitry, the pitch of the electrode array and size of each electrode may be selected by taking into consideration the pitch and density of the CMOS active circuitry. For example, in some embodiments at least 8, at least 10, or at least 4000 recording circuits may be provided within the semiconductor substrate, and the electrode array may have at least 1000, or at least 4000, or at least 1,000,000 electrodes. In such embodiments, each electrode may have a lateral dimension of no more than 10 μm, or no more than 5 μm, such that the overall lateral extent of the electrode array is contained within the surface of the semiconductor substrate. An electrode array according to aspects of the present disclosure may also be referred to as a CMOS microelectrode array (MEA).
[0088] Referring back to
[0089] CMOS-compatible, wafer-scale, multi-well platform that can be used for biomedical or other applications, and methods to operate the same. In some applications, circuitry is provided underneath a multiple-well array to electrically interface with electrodes in the wells. The platform may sometimes be referred to as a CMOS-Multiwell Platform. The inventors have recognized and appreciated that to interface with electrodes in a large array, circuitry may be fabricated on a single silicon (Si) wafer having a dimension that is at least the same or larger than that of the multiple-well array. According to one aspect of the present disclosure, standard CMOS fabrication processes such as those known to be used in a standard semiconductor foundry may be used, e.g., without expensive customization for complex fabrication procedures, and thus the production cost can be lowered in some cases. The CMOS-Multiwell Platform according to some aspects of this disclosure can be used in applications including electrophysiology studies and general cell assessment using electrical methods, and/or in a high throughput format (e.g. 24-, 96-, and 384-well plate formats).
[0090] In some embodiments, the Si wafer is part of a semiconductor device, and has an array of reticle areas, with some or all of the reticle areas having a plurality of circuitry of a same design. The inventors have recognized and appreciated that during manufacturing, reticle areas of a wafer may reuse the same lithographical mask design repeated across the wafer in some cases, thus reducing the cost of tooling and increasing the wafer manufacturing throughput.
[0091] According to an aspect, digital and analog circuitry within a reticle area may be arranged to correspond to one or more wells when the multiple-well array is coupled on top of the wafer. Some embodiments can therefore provide a wafer-scale integration of electrical interface with a multiple-well array by using a manufacturing method that does not dice the wafer and/or is compatible with standard using standard CMOS-compatible techniques to reduce manufacturing cost.
[0092] One aspect of the present disclosure is directed to a technique of mapping the spatial distribution and dimensions of cells using cross-electrode impedance measurements. The mapping may additionally represent a property of individual cells such as adhesion to the surface of a semiconductor substrate. In some embodiments, because cell presence is primarily reflected locally in cross-electrode coupling between a stimulus electrode and nearby recording electrodes, mapping is performed by first choosing an individual electrode as stimulus electrode, and measuring a set of cross-electrode impedance data against other electrodes at locations throughout the electrode array. Subsequently, a different electrode is chosen as stimulus electrode, and a new set of cross-electrode impedance data is measured. The cross-electrode measurements are repeated by sequentially setting electrodes in the electrode array to apply a stimulus signal, and the corresponding set of measurement cross-electrode impedance data may then be processed to generate a value that indicates for each location of the stimulus electrode, whether there is a presence of a cell, or a strength of a cell property. The processed values may then be combined to form a map across the area of the electrode array. In some embodiments, “electro-chemical imaging” of live-cell cultures are demonstrated by high-resolution in situ impedance and electrochemical measurement. Some embodiments are directed to using CMOS-MEAs to perform label-free and non-invasive tracking of cell growth dynamics and accurate measurements of cell-substrate attachment, cell-cell adhesion, and metabolic state.
[0093] Another aspect is directed to providing spatially positioned electrochemical reactions using a patterned electrode array. With a selected number of electrodes in the electrode array, active circuitry in the semiconductor substrate may apply potentials to initiate an electrochemical reaction in the solution regions directly above the selected electrodes. As a result, electrochemistry can be performed selectively at a programmed spatial pattern, based on the size, shape and distribution of the selected electrodes on the surface of the semiconductor substrate.
[0094] In some embodiments, spatially programmed electrochemistry may be used to perform cell patterning. For example, cells adhered to an electrode may be selectively removed from the electrode surface by electrochemically generate small gas bubbles on the electrode.
[0095] In some embodiments, an array of electrochemical electrodes may be used to spatially map analyte concentrations as measured using active circuitry in the semiconductor substrate. One application is an electrochemical mapping of solutions using redox electrochemistry.
[0096] The following applications are each incorporated herein by references in their entireties: U.S. Provisional Patent Application Ser. No. 63/040,439, filed Jun. 17, 2020, by Park, et al.; U.S. Provisional Patent Application Ser. No. 63/040,424, filed Jun. 17, 2020, by Ham, et al.; and U.S. Provisional Patent Application Ser. No. 63/040,412, filed Jun. 17, 2020, by Ham, et al. In addition, the following are each incorporated herein by references in their entireties: a PCT patent application, filed on Jun. 16, 2021, entitled “Complementary Metal-Oxide-Semiconductor (CMOS) Multi-Well Apparatus for Electrical Cell Assessment” and a PCT patent application, filed on Jun. 16, 2021, entitled “Apparatuses for Cell Mapping Via Impedance Measurements and Methods to Operate the Same.”
[0097] The following examples are intended to illustrate certain embodiments of the present invention, but do not exemplify the full scope of the invention.
Example 1: Real-Time Cell Measurements Using a CMOS Microelectrode Array (MEA) and Imaging System
[0098] This example describes electrical imaging of three parameters useful for live-cell assessment (
[0099] In this example, a custom designed CMOS IC is used that parallelizes impedance and electrochemical capabilities across a 64×64=4,096 array of electrodes (
[0100] Each electrode in the array is connected to its own pixel circuit (
[0101]
[0102] In accordance with some aspects, the high channel count (4,096), parallel current and open-circuit potential measurements featured in the measurement techniques in this example provide unique advantages over other MEA devices. For example, measurements as described in this example are prevented in MEA devices that measure the electrode capacitance, voltage with high-pass filters to block DC signals, or current with a small number of channels (<32).
Example 1A: Cell Mapping Using Distribution of Max Current
[0103] This example describes a technique of mapping cells using a CMOS electrode array which contains a 64×64 array of 4,096 platinum electrodes at a 20 μm pitch.
[0104] The inventors have recognized and appreciated that alternating current (AC) impedance measurements between a pair of electrodes can detect cells using the contrast between the insulative cell membrane and conductive culture media. In a classic impedance measurement, solution paths around the cells shunt the measurement and lower detection sensitivity, as the solution contribution of the measured electrode-to-electrode current is far larger than the small change of current due to the cells. The device as disclosed herein improves detection sensitivity by instead measuring a change of electric field distribution due to the cells.
[0105] An AC voltage (1.9 kHz frequency, 200 mV amplitude) was applied to one electrode and the resultant AC currents were measured through the remaining 4,095 electrodes using transimpedance amplifiers. The result is illustrated in
[0106] The measured cross-electrode current versus distance to stimulation pixel data plot 303 in
[0107] In this example, a fluorescent nuclei MDCK cell line was used for optical confirmation.
[0108]
[0109] The max current value (Ie) determined for each stimulation electrode location using any suitable method based on the set of cross-electrode currents measured from the recording electrodes. The determination may be a simple comparison of absolute arithmetic values of the cross-electrode currents, and may additionally include data processing such as noise filtering, background subtraction, or any suitable signal processing technique known in the field prior to the comparison. Processing and comparison of the current values may be performed after digitization of the measured current values, and using a processing unit such as processing unit 120 as shown in
Example 2: High Spatial Resolution Mapping Using Cross-Electrode Currents
[0110] This example describes a method to generate an up-scaled map of the cross-electrode coupling that has a higher spatial resolution than the pitch of the electrode array.
[0111] According to some embodiments, the nearest neighbor cross-electrode measurements may be used for each stimulation electrode.
[0112]
[0113] To measure the cell-substrate attachment, a change of cross-electrode field is formed. Instead of applying bias between two electrodes, bias is applied from one electrode to all remaining electrodes. This allows the field lines starting from the stimulation electrode and extending far up into the culture well to terminate on electrodes far away the stimulation. Otherwise, these field lines would need to curl back towards the adjacent electrode, increasing the amount of measured current not related to the immediate cell-electrode interface.
[0114] The interface may be modeled using a cross-sectional type model to increase spatial resolution. If we assume Z.sub.s<<Z.sub.te, Z.sub.e,1, and Z.sub.e,2, which according to some aspects are found to be valid for most measurement, then:
[0115] The measured cross electrode current can also be written and expressed in terms of (Eq. A1),
[0116] To determine Z.sub.e,1 and Z.sub.e,2, the sum of the measured current across the array is used when the stimulus is applied to an electrode n,
[0117] Z.sub.s can then be solved for from (A3) and (A2),
[0118] which uses all measured currents.
[0119] To generate a high-spatial map of the Z.sub.s, nearest neighbor cross-electrode measurements were used for each stimulation electrode: a 3×3 grid is used for each electrode (except those at the edges of the electrode array). See
[0120] In the example shown in
[0121] where V.sub.AC is the amplitude of the applied AC voltage, I.sub.xy is the magnitude of the AC current measured by electrode y when the AC signal is applied to electrode x, and I.sub.x [I.sub.y] is the sum of the magnitude of the AC currents measured by all other electrodes when the AC signal is applied to electrode x [y]. The edge normalized impedance values are then calculated as,
[0122] where the square root of 2 was determined to normalize the difference in distance between the edge and corner electrodes. The center normalized impedance value is then determined as,
Z.sub.55=median(Z.sub.52, Z.sub.54, Z.sub.56, Z.sub.58) (Eq. 3)
[0123] The use of the cross-electrode currents not only increases the effective spatial resolution in comparison to using the max of the current distribution but it also allows for unadhered cells, which cause a decrease in the cross-electrode current, to be mapped.
[0124]
[0125]
Example 3: Quantifying Cell Adhesion
[0126] This example describes a method using cross-electrode impedance mapping to quantify cell adhesion.
[0127] Ethylenediaminetetraacetic acid (EDTA) is applied to the cells. EDTA is a calcium chelator that removes Ca.sup.2+ needed for integrin proteins to maintain cell adhesion. With EDTA applied, the cells quickly detach over the time course of ˜50 min. The EDTA is then washed out by adding normal culture media, where the cells re-attach over the time course of ˜200 min.
[0128] The detachment and reattachment of the cells is captured with high spatial and time resolution using cross-electrode impedance mapping, as demonstrated in
[0129]
[0130] To show a biologically relevant example of quantifying cell adhesion, a genetically modified MDCK cell line was measured wherein tetracycline was used to turn on and off a RasV12 and GFP gene. The result is shown in
[0131] RasV12 is an oncogene and has been known to increase cell metabolism and decrease cell adhesion when strongly expressed, which together cause cancer-like cell growth and tumors. Originally, tetracycline was kept out of the media and the cells were adhered as normal. When tetracycline was introduced, the genes were expressed causing an increase in GFP and a decrease in cell adhesion. Removal of tetracycline then reversed the cell adhesion to cause the cells to more strongly adhere while also decreasing overall GFP expression; some portions of the cell culture did not turn off as strongly as others. The effects on cell adhesion were quantitatively compared to a control culture which did not have tetracycline introduced, as shown in
Example 4: Frequency Response
[0132] This example describes the effect of frequency used in the cross-electrode impedance measurements.
[0133] The frequency of mapping was swept to determine the best frequency for measuring the cell adhesion using cross-electrode impedance mapping.
Example 5: Cell-to-Cell Adhesion
[0134] The previous examples are directed to how to map cells and their adhesion over time via a cross-electrode impedance measurement, as depicted in
[0135] This example describes a method to measure cell-to-cell attachment, or how well connected the cells are to each other. Cells in culture not only attach to the surface, but also to each other via cell-cell connections. The tightness of these connections defines the permeability of a cell sheet and is important for epithelial tissues which act as barriers of the body surfaces, internal organ linings, and other tissues. In this example, this barrier function is measured by performing a map of the transepithelial impedance, Z.sub.te. In this way, the cell-cell connectivity could be assessed using electrodes only covered by cells to mitigate any holes while also allowing for spatial heterogeneity assessment.
[0136] In this example, the stimulation protocol is modified to measure the vertical field component 1014 as shown in the diagram in
[0137]
[0138] The calculation of transepithelial impedance Zte using the schemes in
[0139] To measure cell-to-cell attachment, or how well connected the cells are to each other, we can modify the stimulation protocol to measure the vertical field component in
[0140] In the parallel scheme in
[0141] In either case, the measured vertical current I.sub.te,n can be expressed,
[0142] Using (A3), we can then solve for Z.sub.te,
[0143] For measurements, it was determined that mid-frequencies from ˜1-5 kHz are best correlated with the cell-cell connectivity (see also Example 15, below). For the PtB electrodes, Z.sub.e,n is then sufficiently smaller than Z.sub.te (see also Example 15, below) such that it is estimated that:
[0144] For Z.sub.te experiments with just Pt electrodes, the I.sub.n measurement from the cell-substrate impedance is subtracted. Due to the scanned array measurement to calculate Z.sub.te,no ref using a 3×3 set of electrodes, the total map generated is 62×62 pixels, as the peripheral electrodes do not have neighboring biased electrodes to create the vertical field. The measurement versus the reference creates a map containing 64×64 pixels.
Example 5A: Metabolic State Mapping Via Extracellular Redox Potential, Vredox
[0145] Beyond impedance measurements, platinum electrodes have been used for both potentiometric sensing of oxygen and extracellular redox monitoring. This example demonstrates that we could use the proximate location of Pt electrodes directly underneath live cells to map the extracellular redox potential, V.sub.redox, in situ to monitor the redox environment of the cells and even O.sub.2 consumption to map out the metabolic state of cell cultures.
[0146] To accomplish the measurement, the pixel amplifier is configured as a buffer, as shown in the schematic diagram in
[0147] In general, cells use energy arising from the movement of electrons from oxidizable organic molecules (e.g. glucose) to O.sub.2 during aerobic metabolism. To help mediate these electron flows, a general reducing environment is created by the thiol-compound glutathione (GSH) which is often considered to be the cellular redox buffer. In simplified terms, the redox potential of the cell is then a balance between O.sub.2 pulling the potential up (oxidizing) and GSH pulling the potential down (reducing). The redox environment is not only important for electron transfer, but also for neutralizing harmful reactive oxygen species, cell-cell signaling, and regulating the state of the cell. For example, ranging from negative to positive, the redox potential can determine if a cell is in a state of proliferation, differentiation, apoptosis, or necrosis.
[0148]
[0149] One goal of this example is to investigate what information the proximate V.sub.redox could provide by pairing it with the impedance techniques to monitor cell growth (
[0150] To further explore the Vredox signal origin, the O.sub.2 dependence was tested via an oxygen purge on a separate MDCK cell culture. Upon the O.sub.2 removal, the signal difference between regions with cells and without was eliminated. To complement, the GSH based reducing capacity was tested via an oxidative titration. Ferricyanide, [Fe(CN)6].sup.3−, was chosen for the titration due to its previous non-toxic use in cell-cultures and its oxidizing half-cell potential in comparison to the cellular environment. The media showed a 4 μM reducing capacity while the cells had a much larger capacity of >200 μM.
[0151] Taken together, these measurements show that the measured V.sub.redox is related to both the in situ [O.sub.2] and [GSH]-based reducing capacity of the cells. We theorize that with aerobic respiration, the [O.sub.2] lowers from its normal dissolved concentration of ˜200 μM at atmospheric conditions which lowers V.sub.redox until it is regulated by the extracellular reducing potential of the cells. Therefore, though it is difficult to quantify oxygen consumption rate with our technique, the V.sub.redox measurement of the extracellular redox potential can be useful for monitoring the metabolic state of cells, as it can show both the usage of O.sub.2 and the reducing environment of cells. Therefore, the more negative signal on the leading edge of the cell sheet (
Example 6: Antibody-Cell Binding
[0152] Screening for antibody-cell binding can be low-throughput due the need for either fluorescent tagging of the antibodies, which requires wash steps to remove non-bound fluorescent antibodies, or the need for a special optical measurement such as surface plasmon resonance (SPR). According to one aspect, the cross-electrode impedance technique described herein may offer the ability to measure the antibody-cell binding event through either the cell-to-substrate or cell-to-cell adhesion measurements. With the binding of an antibody on the underside of the cell, the gap distance becomes effectively smaller leading to a decrease in the amount of cross-electrode current measured. Likewise, with antibody binding to the sides of the cells, the cell-to-cell gap distance should also become smaller, leading to a decrease in the amount of vertical current measured. Being able to perform such antibody binding without labels then allows for different antibodies to be added in sequence without the need for wash steps, greatly improving throughput.
Example 7: Cell Patterning Through Electrochemical Gas Generation
[0153] This example describes a method to pattern cells on top of an electrode array. The inventors have recognized and appreciated that small gas bubbles can be electrochemically generated to generate small holes in the cell membrane to kill the cells via depolarization. After death, cells will then detach from the surface, as illustrated in the schematic diagram in
[0154] Without wishing to be bound to a particular theory, the inventors recognized that for most inert electrode materials (platinum, gold, etc.) hydrogen gas can be generated by adjusting the electrode potential below the hydrogen ion/hydrogen gas redox half-cell reduction potential) (E.sup.0),
2H.sup.++2e.sup.−H.sub.2(g)E°=0.00V (Eq. 4)
[0155] or oxygen gas can be generated by adjusting the electrode potential above the oxygen gas/water redox potential,
O.sub.2(g)+4H.sup.++4e.sup.−2H.sub.2O E.sup.0=+1.23V (Eq. 5)
[0156] Likewise, as most cell media contain chloride salts, chloride gas may also be generated by adjusting the electrode potential above the chlorine gas/chloride redox potential,
Cl.sub.2(g)+2e.sup.−2Cl.sup.−E°=+1.36V (Eq. 6)
[0157] Accordingly, cell removal may be performed by selectively applying a pre-determined potential that is above a redox potential for generation of a gas at one or more electrode locations. The potential may be applied, for example by connecting one or more stimulus source circuits 110 in
[0158] For more controllable patterning, an electrode current can be used to set the electron transfer rate and therefore the rate of gas generation. Controlling the rate of gas generation can optimize the selective electrochemical reaction as large bubbles can form on the surface by using too fast of a gas generation rate, blocking the electrodes from solution.
[0159]
Example 8: Cell Spatial Patterning and Defining a Co-Culture
[0160] This example describes spatial patterning of cells and definition of a co-culture using an electrode array.
[0161] A CMOS electrode array as shown in
[0162]
Example 9: Directed Cell Evolution by Removing Culture Heterogeneity
[0163] This example describes a method of directed cell evolution to eliminate cells from the cell culture whose properties are not desired.
[0164]
Example 10: Wound Healing Assay
[0165] This example describes a combined application of both the cross-electrode impedance mapping and cell patterning is a wound healing assay.
[0166] These assays gauge cell growth rate and metabolism and can be useful for screening drugs affecting these parameters. Compared to the electrochemical patterning described herein, other tools mechanically generate a wound in a cell culture via a mechanical scratch which is both difficult to control and limiting in terms of wound pattern.
[0167] In this example, a wound is made in MDCK cells and then the growth is mapped in real-time.
Example 11: Molecular Delivery
[0168] This example describes a technique using planar electrodes for membrane permeabilization and molecular delivery. Unlike electroporation, which applies a concentrated electric field to break down the cell membrane, planar electrode permeabilization works via gas bubble formation, similar in concept to the patterning techniques discussed herein. Unlike patterning cells, where cells are killed to perform the patterning, for molecular delivery smaller holes are created on the cells that will then reseal over time.
[0169]
[0170]
[0171] In both experiments shown in
[0172] Such delivery capabilities can be readily used for screening membrane impermeable compounds for their effects on cells and cell-to-cell interactions. The spatial capabilities of the electrode array, in which cells can be chosen for delivery, can be useful in this latter application of cell-to-cell interactions where the delivered cell and its undelivered neighbors can be measured for the effects of the compounds. Without such delivery capabilities, the membrane impermeable compounds would otherwise need to be chemically modified for delivery, which is expensive and time-consuming, or delivered using a micropipette on a single-cell basis, which is also expensive and time-consuming. Beyond compounds, RNA/DNA/plasmids can also be delivered for applications to synthetic biology.
Example 12: Serial Delivery for Cross-Effect Analysis
[0173] This example describes a multi-step delivery of compounds in cells using an electrode array.
[0174]
Example 13: Extracellular Electrochemical Mapping
[0175] This example describes electrochemical mapping using redox electrochemistry on the electrode array.
[0176] Electrochemical measurements of cells using electrodes can use a single, large working electrode to measure bulk concentrations of analytes in solution. Such electrochemical electrode-based measurements include the Clark electrode for dissolved oxygen concentration measurement and hydrogen ion concentration (pH) measurement. According to an aspect of the present disclosure, an array of electrochemical electrodes may be used to spatially map analyte concentrations measured via electronics within a CMOS integrated circuit. Such electrochemical mapping can then be applied for cell analysis of cells cultured directly on top of the electrode array.
[0177] In this example, to demonstrate the capability for electrochemical mapping using an array of electrodes measured using a CMOS integrated circuit, cyclic voltammetry is performed using a common redox couple of ferricyanide/ferrocyanide, [Fe(CN).sub.6].sup.3−/[Fe(CN).sub.6].sup.4−.
[Fe(CN).sub.6].sup.3−+1e.sup.−[Fe(CN).sub.6].sup.4−E°=+0.36V (Eq. 7)
[0178]
[0179] In this experiment, a subset 13×13=169 of a 64×64 array of electrodes was connected to the same number of respective transimpedance amplifiers with a cyclic linear voltage ramp applied, as illustrated in the schematic diagram in
[0180] The open-circuit potential of the electrodes can also be used to measure the concentration of chemical species in solution. For a high-concentration of a redox couple in solution, the open-circuit potential of platinum electrodes in solution can be determined by the Nernst equation. The Nernst equation relates the reduction potential of an electrochemical reaction to the standard electrode potential, temperature, and activities of the chemical species undergoing reduction and oxidation,
[0181] where E.sub.H is the electrode voltage potential with respect to the standard hydrogen electrode (S.H.E), E.sup.0 is the half-cell reduction potential, φ.sub.t is the thermal voltage (˜25.7 mV at 25° C.), [Ox]/[Red] is the concentration of the oxidized/reduced chemical species, and n is the number of electrons transferred in the cell half reaction. For the ferricyanide/ferrocyanide reaction, measurement of the open-circuit potential then reflects the ratio of the concentrations of these ions in solution.
[0182] In this example, the potential of the remainder of the electrode array was measured. In particular, ferrocyanide generation and transport across a CMOS electrode are mapped using open circuit potential.
[0183] A cyclic potential is applied to a group of 13×13 electrodes (with 9 electrodes excluded within the group of 13×13 electrodes, as illustrated in
[0184] In summary, for the cyclic voltammetry, measuring the open-circuit around the electrode shows the flow of ferrocyanide towards the upper right corner of the device.
Example 14: Electrochemical Oxygen Mapping of Cells
[0185] This example describes a technique applying electrochemical mapping to cell analysis. For example, a Clark electrode based on platinum may be measured by applying a pulsed voltage or a voltage pulse sequence which sequentially oxidizes and then reduces the platinum. As platinum oxide blocks oxygen reduction, the current drops to zero after the oxide is formed. When the oxide is then reduced, the platinum electrode passes a negative current due to the presence of oxygen,
O.sub.2(g)+4H.sup.++4e.sup.−2H.sub.2O E.sup.0=+1.23V (Eq. 9)
[0186] The local oxygen concentration is then consumed, and the electrode waits for the further diffusion of additional oxygen to the electrode to pass current. Therefore, the rate of the equation is limited by oxygen diffusion which is proportional to the oxygen concentration in solution and can be measured by measuring the electrode current.
[0187] In an experiment using an electrode array, a measurement was performed using a salt solution (phosphate-buffered saline) exposed to ambient air and then subsequently purged with nitrogen gas to reduce the oxygen concentration.
[0188] Comparing the current I.sub.el before and after the purging shows a marked reduction. Experiments were then performed with HEK293 cells, and the results are shown in
[0189] Cells consume oxygen as a part of aerobic metabolism, therefore the oxygen concentration around cells is smaller than places without cells. Indeed, mapping the electrode current across the array shows the location of the cells has a smaller magnitude of current than places without cells, as imaged using a cross-electrode impedance map. The left and bottom edges of map 2208 also show a larger magnitude of current, which is attributed to edge effects and the increased diffusion/mass transport.
Example 15: Effects of Platinum Black and Frequency on Cell Barrier Sensitivity
[0190] In this example, platinum black (PtB) was used to lower the electrode impedance, Z.sub.e, to improve cell barrier measurement sensitivity.
[0191] Having thus described several aspects of at least one embodiment of this invention and examples thereof, it is to be appreciated that various alterations, modifications, and improvements will readily occur to those skilled in the art. Such alterations, modifications, and improvements are intended to be part of this disclosure, and are intended to be within the spirit and scope of the invention. Further, though advantages of the present invention are indicated, it should be appreciated that not every embodiment of the technology described herein will include every described advantage. Some embodiments may not implement any features described as advantageous herein and in some instances one or more of the described features may be implemented to achieve further embodiments. Accordingly, the foregoing description and drawings are by way of example only.
[0192] Various aspects of the present invention may be used alone, in combination, or in a variety of arrangements not specifically discussed in the embodiments described in the foregoing and is therefore not limited in its application to the details and arrangement of components set forth in the foregoing description or illustrated in the drawings. For example, aspects described in one embodiment may be combined in any manner with aspects described in other embodiments.
[0193] Also, the invention may be embodied as a method, of which an example has been provided. The acts performed as part of the method may be ordered in any suitable way. Accordingly, embodiments may be constructed in which acts are performed in an order different than illustrated, which may include performing some acts simultaneously, even though shown as sequential acts in illustrative embodiments.
[0194] Use of ordinal terms such as “first,” “second,” “third,” etc., in the claims to modify a claim element does not by itself connote any priority, precedence, or order of one claim element over another or the temporal order in which acts of a method are performed, but are used merely as labels to distinguish one claim element having a certain name from another element having a same name (but for use of the ordinal term) to distinguish the claim elements.
[0195] The terms “approximately” and “about” may be used to mean within ±20% of a target value in some embodiments, within ±10% of a target value in some embodiments, within ±5% of a target value in some embodiments, and yet within ±2% of a target value in some embodiments. The terms “approximately” and “about” may include the target value.